Preferential Treatment: US FDA Asks Patients For Their Input

 
• By Ferdous Al-Faruque
Shuren_Jeff_1200
Michael McCaughan (left) speaking with CDRH Director Jeff Shuren at the Reagan-Udall Foundation for FDA on 2 May. • Source: Ferdous Al-Faruque

More from Regulation

More from Policy & Regulation